Navigation Links
MAQUET Orthostar II

ProductsMAQUET Orthostar II
Company Getinge USA, Inc.
Item MAQUET Orthostar II
Features The power adjustable back plate can be completely removed, allowing attachment of special-purpose accessories; two (2) traction bars beneath the seat plate with 2 separately adjustable pivot joints each for extension of the extremities with unimpeded use of the C-arm. Side rails are provided at the table top frame near the seat plate. Guide rails beneath the seat plate allowing X-ray film cassette insertion (24 x 30 cm) from either the right or the left hand side for the hip area. Detachable pads made of special foam core (SFC), 50 mm thick, radiotranslucent and electrically conductive on plastic supporting plates.
Description The ORTHOSTAR table is the most versatile orthopedic/trauma table available today. It was designed for both lower body and upper body traction with an integrated shoulder attachment. The ORTHOSTAR is a special purpose operating table for your most challenging procedures.
Info Getinge USA, Inc.
Customer Service: (800) 475-9040

Related medicine products :

1. MAQUET Alphamaxx Surgical Table
Black multi-pinhole occluder
9 inch double ended with one end black and the other end with 49 holes
Double Ended Occluders
49 pinholes, black
Medicine Products:
(Date:8/20/2008)...r-old Contestant Wins Trip to Little League Baseba... The National Spit Tobacco Education,Program (NSTE...st today,and encouraged young baseball players to...ddiction and the health risks of using tobacco pro...year,s slogan contest winner is,Joe Reck, a nine-y...
(Date:8/20/2008)...cently enacted Medicare Improvement Law immediatel...re Advantage insurance companies .../PRNewswire/ -- When the House and Senate,overrode...gislation,protecting Medicare beneficiaries, they ...e Advantage plans during one of the busiest months...
(Date:8/20/2008)...T CREEK, Calif., Aug. 20 /PRNewswire-FirstCall/ --... reported preliminary income from,continuing opera...f $27.5,million, or $0.76 per diluted share, inclu...er diluted share, related to provisions for store,... a 6.8 percent increase,compared with income from ...
(Date:8/20/2008)...FIELD, Mich., Aug. 20 /PRNewswire/ -- WXYZ- TV/Cha...llness Promotion will give thousands of,Detroit me...ALTHY LIVING,FOR KIDS" program. This year the prog....m. to 5 p.m. at the Charles H. Wright Museum of A...77, "Healthy Living for Kids",has provided free im...
Breaking Medicine News(10 mins):Health News:Slogan Contest Educates Young Baseball Players About the Dangers of Tobacco Use 2Health News:Medicare Advantage Plans Struggle to Comply With New Federal Law 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 2Health News:Longs Drug Stores Corporation Reports Second Quarter Results 3Health News:Longs Drug Stores Corporation Reports Second Quarter Results 4Health News:Longs Drug Stores Corporation Reports Second Quarter Results 5Health News:Longs Drug Stores Corporation Reports Second Quarter Results 6Health News:Longs Drug Stores Corporation Reports Second Quarter Results 7Health News:Longs Drug Stores Corporation Reports Second Quarter Results 8Health News:Longs Drug Stores Corporation Reports Second Quarter Results 9Health News:Longs Drug Stores Corporation Reports Second Quarter Results 10Health News:Longs Drug Stores Corporation Reports Second Quarter Results 11Health News:Longs Drug Stores Corporation Reports Second Quarter Results 12Health News:Longs Drug Stores Corporation Reports Second Quarter Results 13Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 2Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 3
...-moon has urged the G8 summit of the world's top i...limate change, warning that inaction would be cos...at Heiligendamm in Germany, Ban said the eight par...d implement a long-term global framework to tackle...
...cannot keep up with demand. Two experts in this we...people want to donate unless there is evidence to...0% of the UK population support organ donation, ye...h to donate, writes Veronica English, Deputy Head ...
...ogical treatments such as hypnotherapy have the po...el syndrome (IBS), say researchers in this weeks ...nal physical treatments often do not work very wel... that their symptoms are being ignored, downplayed...
...aiming an interesting manifestation of post trauma...n. And when he frequented chat rooms while at w...ant, IBM, fired him. Now the 58-year old James P... suing them for $ 5 million for "wrongful dismissa...
Other Medicine News:Health News:Is Presumed Consent the Answer to Organ Shortages? 2Health News:Hypnotherapy may Help Patients With Irritable Bowel Syndrome 2Health News:Sacked Employee Says Stress Led to His Sex Addiction 2
(Date:8/19/2008)...19 /- VION,PHARMACEUTICALS,...had,entered into an agreement with the Dutch-Belgi... (the "HOVON") to conduct a clinical trial of,laro... remission-induction,therapy in patients aged 18-6...emia (AML) and high-risk myelodysplasia (MDS)., A...
(Date:8/18/2008)...ewswire/ -- The next time you consider popping a,p... worth counting sheep,instead. A senior psychiatri..., Calif. has found evidence that taking sleeping p...r., Daniel F. Kripke, M.D.,s article, based on a ...d cancer, has just been published in the Journal,o...
(Date:8/18/2008)...st 18 /- Oramed,Pharmaceuti...m ), a developer,of oral delivery systems, announc...tudy to Assess the Safety, Pharmacokinetics (PK) a...ulations in Healthy,Subjects," has been chosen for...of the European Association for the Study of Diabe...
(Date:8/18/2008)...l trial currently in Phase I -, PRINCETON, N.J. a...peutics Inc., a clinical stage biotechnology compa... against life-threatening and life-altering,infect...ent No. 7,371,772,B2 by the U.S. Patent and Tradem...tagonist currently in Phase I development for the ...
Breaking Medicine Technology:Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy 2Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy 3Prescription Sleeping Pill Use Tied to Cancer 2Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome) 2Will botox be the aspirin of the 21st century 3F 14566 1Will botox be the aspirin of the 21st century 3F 14566 2Safe at Any Age 3A Octogenarians Do As Well as Younger Patients With Interventional Radiology Arterial Procedures 14563 1Safe at Any Age 3A Octogenarians Do As Well as Younger Patients With Interventional Radiology Arterial Procedures 14563 2Safe at Any Age 3A Octogenarians Do As Well as Younger Patients With Interventional Radiology Arterial Procedures 14563 3New England Technology Foundation Announces Connecting for Childrens Charities 2008 Event 14560 1New England Technology Foundation Announces Connecting for Childrens Charities 2008 Event 14560 2Few Women Hear About Uterine Fibroid Embolization Treatment Option Directly From Gynecologists 14557 1Few Women Hear About Uterine Fibroid Embolization Treatment Option Directly From Gynecologists 14557 2Few Women Hear About Uterine Fibroid Embolization Treatment Option Directly From Gynecologists 14557 3Few Women Hear About Uterine Fibroid Embolization Treatment Option Directly From Gynecologists 14557 4
...AM, Mass., May 10, 2007 /PRNewswire-FirstCall/ -- ...lts from a Phase 2,clinical trial to evaluate the ...nt to improve the assessment of pancreatic duct,st...study showed an,improvement in sensitivity of dete...c duct of approximately 20% with no loss in,specif...
...OUSE STATION, N.J.--(BUSINESS WIRE)-May 10, 2007--...ishing results from two,Phase III studies of Merck... Human Papillomavirus (Types 6, 11, 16, 18),Recomb...ded 100,percent protection against cervical, vagin...s Gardasil is designed to protect,against, HPV typ...
Other Medicine Technology:Repligen Reports Positive Phase 2 Clinical Trial Results of,Secretin for MRI Imaging of the Pancreas 2Repligen Reports Positive Phase 2 Clinical Trial Results of,Secretin for MRI Imaging of the Pancreas 3Repligen Reports Positive Phase 2 Clinical Trial Results of,Secretin for MRI Imaging of the Pancreas 4New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 2New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 3New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 4New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 5New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 6New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 7New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 8New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 9New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 10New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 11New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 12New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 13New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 14New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 15New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 16New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 17New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 18New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 19New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 20New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 21New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 22New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 23New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 24New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 25New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 26New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 27New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 28New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 29New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 30New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 31New England Journal of Medicine Publishes New Data on Gardasil,Merck's Cervical Cancer Vaccine 32